Skip to main content
Clinical Trials/DRKS00027547
DRKS00027547
Recruiting
Not Applicable

German Dementia Registry - GDR

Klinik für Neurologie des Uniklinikums Aachen0 sites500 target enrollmentApril 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
F03
Sponsor
Klinik für Neurologie des Uniklinikums Aachen
Enrollment
500
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2022
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinik für Neurologie des Uniklinikums Aachen

Eligibility Criteria

Inclusion Criteria

  • Ability of the participant and/or his/her legally authorized representative (e.g., spouse or legal guardian), as appropriate and applicable, to understand the purpose and risks of the register and provide signed and dated informed consent and authorization to use protected health information (PHI) in accordance with national and local privacy regulations.
  • Participating patients must have a diagnosis of SCI, MCI, early dementia, moderate dementia or severe dementia of different etiology (i.e. Alzheimer’s Disease, Frontotemporal Dementia, Parkinson’s Disease, Lewy\-Body Dementia, Progressive Supranuclear Palsy, Corticobasal Degeneration, Normal Pressure Hydrocephalus, Major Depression; Vascular Dementia; TDP\-43 associated limbic encephalopathy (LATE), Mixed Dementia AD \+ VaD, Prion\-Associated Dementia) with fluid and/or imaging biomarkers.
  • At least 18 years of age.
  • Inclusion Criteria for familiy member:
  • At least 18 years of age.
  • Patient was included in the registry
  • Family member is strongly involved to the patient's life according to the patient’s statement
  • Ability of the participant, as appropriate and applicable, to understand the purpose and risks of the register

Exclusion Criteria

  • Unable or unwilling to provide informed consent.
  • No available biomarkers such as cerebrospinal fluids (CSF) amyloid beta 1\-42, amyloid beta 1\-40, amyloid beta 1\-42/amyloid beta 1\-40 ratio, total tau and phospho\-tau, amyloid or tau imaging.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
The German Multiple Sclerosis Registry of the German MS SocietyG35G37.8G04.9G04.8Multiple sclerosisOther specified demyelinating diseases of central nervous systemEncephalitis, myelitis and encephalomyelitis, unspecifiedOther encephalitis, myelitis and encephalomyelitis
DRKS00011257MS Forschungs- und Projektentwicklungs-gGmbH50,000
Completed
Not Applicable
General practitioner documentation of dementia diagnosis: a randomized controlled trial using the interventions of education and audit feedback
ACTRN12612001140842James Cook University80
Not yet recruiting
Not Applicable
German Lupus RegistryM32Systemic lupus erythematosus
DRKS00032997niversitätsklinikum Köln - Klinik II für Innere Medizin500
Recruiting
Not Applicable
German Network for Personalized Medicine (DNPM) - EvaluatioPatients with serious, advanced cancer who have undergone guideline-based therapy and patients with rare tumors for which no guideline-based therapy exists were enrolled.
DRKS00031622Zentrum für Personalisierte Medizin, Universitätsklinikum Tübingen6,000
Recruiting
Not Applicable
Freiburg registry for parkinsonian syndroms and dementiasG20G23.9G23.2G23.1G31.82G30G31.0G91.2G23.3I67.3Parkinson diseaseDegenerative disease of basal ganglia, unspecifiedMultiple system atrophy, parkinsonian type [MSA-P]Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]Alzheimer diseaseCircumscribed brain atrophyNormal-pressure hydrocephalusMultiple system atrophy, cerebellar type [MSA-C]Progressive vascular leukoencephalopathy
DRKS00017454Klinik für Neurologie und NeurophysiologieUniversitätsklinikum Freiburg2,000